Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Baclofen (intrathecal)
Generic Name
Baclofen
Active Ingredient
BaclofenCategory
gamma-Aminobutyric Acid-ergic Agonist [EPC]
Variants
2
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Baclofen (intrathecal), you must consult a qualified healthcare professional.
Detailed information about Baclofen (intrathecal)
Baclofen is a skeletal muscle relaxant and GABA-B agonist used primarily to treat spasticity associated with multiple sclerosis and spinal cord injuries. It works by inhibiting monosynaptic and polysynaptic reflexes at the spinal level.
For the treatment of spasticity, the goal of baclofen therapy is to find the lowest effective dose that reduces symptoms without causing excessive side effects like weakness or drowsiness. Dosage must be individualized and titrated (gradually increased) carefully.
A typical titration schedule for adults often follows this pattern:
The maximum recommended daily dose is generally 80 mg (20 mg four times daily), although some patients may require higher doses under strict medical supervision. It is critical not to rush this process; gradual titration allows the body to acclimate to the medication's effects on the central nervous system.
Baclofen is used in children to treat spasticity, often associated with cerebral palsy or spinal cord injury. However, its use in children under the age of 12 is often considered off-label or based on specific institutional protocols. For children aged 12 and older, the dosage is generally similar to adult titration, starting at low doses (e.g., 5 mg two to three times daily) and increasing slowly. Pediatric dosing is often calculated based on weight (e.g., 0.75 to 2 mg/kg/day). Parents must work closely with a pediatric neurologist to ensure the dose is safe and effective for the child's developmental stage.
Because baclofen is primarily excreted by the kidneys, patients with impaired renal function are at a high risk of drug accumulation and toxicity (including confusion and coma). For patients with a creatinine clearance of less than 30 mL/min, the dose should be significantly reduced—often starting at 5 mg once or twice daily—and monitored with extreme caution.
Since the liver plays a minor role in baclofen metabolism, dose adjustments are generally not required for patients with liver disease. However, clinical judgment is always advised.
Older adults are more sensitive to the CNS effects of baclofen. They are at an increased risk of confusion, hallucinations, and falls. Healthcare providers typically start elderly patients on the lowest possible dose and titrate even more slowly than in younger adults.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not take two doses at once to make up for a missed one. Consistent dosing is vital to prevent the return of spasms and to avoid withdrawal symptoms.
An overdose of baclofen is a medical emergency. Symptoms may include severe muscle weakness, somnolence (extreme sleepiness), respiratory depression (slowed breathing), pupillary changes, hypothermia, and coma. If an overdose is suspected, contact emergency services or a poison control center immediately. Treatment usually involves supportive care, gastric lavage if caught early, and maintaining respiratory function.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking this medication without medical guidance, as doing so can lead to serious complications.
Most patients taking baclofen will experience some side effects, especially during the initial titration phase as the brain and spinal cord adjust to the increased GABAergic activity. The most frequently reported side effects include:
Baclofen is a powerful central nervous system (CNS) depressant. Its primary safety concern is the potential for excessive sedation and the risks associated with stopping the medication too quickly. Patients must be aware that baclofen can significantly impair mental alertness and physical coordination. Because the drug is cleared by the kidneys, any change in renal function can lead to a rapid increase in drug levels, potentially causing life-threatening toxicity.
As noted in the side effects section, there are no FDA black box warnings for oral Baclofen tablets. However, the intrathecal (spinal injection) form has a black box warning regarding the life-threatening risks of abrupt withdrawal. Patients taking oral baclofen should treat this with similar gravity: never stop the medication abruptly.
While there are few absolute contraindications for drug combinations, certain substances should never be mixed with baclofen due to the extreme risk of CNS depression:
Baclofen is strictly contraindicated in the following circumstances:
In these conditions, the risks of baclofen may outweigh the benefits, or extreme caution is required:
Baclofen is classified as FDA Pregnancy Category C. This means that animal reproduction studies have shown an adverse effect on the fetus, but there are no adequate and well-controlled studies in humans. In animal studies, baclofen has been associated with an increased incidence of omphalocele (abdominal wall defects) and incomplete skeletal ossification.
Use during pregnancy should only be considered if the potential benefit justifies the potential risk to the fetus. If taken during the third trimester, there is a risk of the newborn experiencing withdrawal symptoms (such as tremors and seizures) after birth. Women of childbearing age should discuss contraceptive options with their doctor while on this medication.
Baclofen is excreted into human breast milk in very small quantities. In women treated with oral doses of 20 mg, the amount of drug the infant would receive is estimated to be less than 0.1 mg per day. While this is a low amount, the effects on a nursing infant's developing nervous system are not fully known. Mothers should monitor their infants for signs of excessive sleepiness or poor feeding. A decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Baclofen is a structural analog of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). Its chemical name is 4-amino-3-(4-chlorophenyl)butanoic acid. It acts as a selective agonist at GABA-B receptors. These receptors are G-protein coupled receptors located both pre-synaptically and post-synaptically in the spinal cord and brain.
By suppressing these excitatory signals, baclofen effectively 'dampens' the overactive reflex arcs that cause muscle spasticity.
Common questions about Baclofen (intrathecal)
Baclofen is primarily used to treat spasticity, which is a condition characterized by stiff, tight, or aching muscles and involuntary muscle spasms. It is most commonly prescribed for individuals with multiple sclerosis (MS) or those who have suffered spinal cord injuries or diseases. By acting on the spinal cord's reflex centers, it helps to relax the muscles, improve mobility, and reduce associated pain. While its primary use is for these neurological conditions, doctors may sometimes use it off-label for other issues like chronic hiccups or certain types of nerve pain. Always use this medication only for the condition specifically diagnosed by your healthcare provider.
The most frequent side effects reported by patients taking baclofen include significant drowsiness, dizziness, and muscle weakness. Many people also experience nausea, fatigue, and a general feeling of being 'foggy' or lightheaded, especially when first starting the drug or increasing the dose. These symptoms often occur because the medication slows down certain signals in the central nervous system. Other common issues can include constipation, headache, and increased frequency of urination. Most of these side effects are temporary and tend to diminish as your body becomes accustomed to the medication over several weeks.
No, you should strictly avoid drinking alcohol while taking baclofen. Both baclofen and alcohol are central nervous system depressants, meaning they slow down brain activity and respiratory function. When taken together, they can dangerously intensify each other's effects, leading to extreme sedation, severe dizziness, and a significantly increased risk of respiratory failure or accidental overdose. This combination can also lead to increased confusion and a higher risk of falls or injuries. It is essential to discuss your alcohol consumption habits with your doctor before beginning treatment with this medication.
Baclofen is classified as a Pregnancy Category C medication, which means its safety during human pregnancy has not been fully established. Animal studies have suggested that high doses may cause birth defects, such as problems with the abdominal wall or bone development. There is also a risk that a newborn could experience withdrawal symptoms, including tremors or seizures, if the mother takes baclofen late in pregnancy. Because of these risks, baclofen is generally only used during pregnancy if the potential benefits to the mother clearly outweigh the risks to the developing fetus. You must inform your doctor immediately if you are pregnant or planning to become pregnant while taking this drug.
The time it takes for baclofen to work can vary depending on the individual and the condition being treated. Some patients may notice a slight reduction in muscle spasms within a few hours of taking their first dose, as the drug reaches peak levels in the blood fairly quickly. However, the full therapeutic effect for chronic spasticity usually takes several days or even weeks to become apparent. This is because the dose must be increased slowly (titrated) to find the most effective level while minimizing side effects. Your doctor will likely start you on a low dose and gradually increase it, so patience is key during the initial phase of treatment.
You should never stop taking baclofen suddenly without consulting your healthcare provider first. Abruptly discontinuing the medication can lead to a serious withdrawal syndrome, which may include symptoms such as hallucinations, seizures, high fever, and a severe return of muscle spasticity. In extreme cases, especially with the intrathecal (spinal pump) form, withdrawal can be life-threatening. If you need to stop the medication, your doctor will provide a schedule to gradually taper your dose over one to two weeks. This slow reduction allows your nervous system to safely readjust to the absence of the drug.
If you miss a dose of baclofen, you should take it as soon as you remember. However, if it is almost time for your next scheduled dose, you should skip the missed dose and simply take the next one at the regular time. Do not take a double dose to make up for the one you missed, as this can increase the risk of side effects or toxicity. Keeping a consistent level of the medication in your system is important for managing muscle spasms effectively. If you find yourself frequently forgetting doses, consider using a pill organizer or setting a daily alarm to help you stay on schedule.
Weight gain is not considered a common or direct side effect of baclofen based on clinical trial data. Most patients do not experience significant changes in weight while taking the medication. However, because baclofen can cause fatigue and drowsiness, some individuals might become less physically active, which could indirectly lead to weight gain over time. Additionally, some patients report fluid retention or 'bloating,' which might be perceived as weight gain. If you notice a sudden or significant change in your weight while taking baclofen, you should discuss it with your healthcare provider to rule out other underlying causes.
Baclofen can interact with many other medications, particularly those that also affect the central nervous system. It is especially dangerous to combine baclofen with opioid pain relievers, benzodiazepines (like Valium or Xanax), or sleep medications, as this can lead to severe respiratory depression. It may also interact with certain antidepressants and blood pressure medications. Because of these potential risks, it is vital that you provide your doctor with a complete list of all prescription drugs, over-the-counter medicines, vitamins, and herbal supplements you are currently taking. Your pharmacist can also help check for any specific drug-drug interactions.
Yes, baclofen is widely available as a generic medication in both tablet and oral solution forms. Generic versions are typically much more affordable than brand-name versions like Lioresal and are required by the FDA to have the same active ingredient, strength, and effectiveness. Most insurance plans cover generic baclofen. When you fill your prescription, the pharmacy may provide the generic version unless your doctor specifically requests the brand name. The appearance of the tablets (color, shape) may vary between different generic manufacturers, but the therapeutic effect should remain the same.
Other drugs with the same active ingredient (Baclofen)
> Warning: Stop taking Baclofen and call your doctor immediately if you experience any of these serious reactions:
Prolonged use of baclofen can lead to the development of tolerance, where higher doses are needed to achieve the same antispastic effect. Long-term use is also associated with a risk of physical dependence. While not 'addictive' in the traditional sense, the body becomes accustomed to the drug's presence, making the process of stopping the medication complex.
While oral baclofen does not currently carry an FDA Black Box Warning, the intrathecal formulation (Lioresal Intrathecal) carries a severe warning regarding Abrupt Discontinuation.
Black Box Summary (Intrathecal): Abrupt discontinuation of intrathecal baclofen, regardless of the cause, has resulted in a withdrawal syndrome characterized by high fever, altered mental status, exaggerated rebound spasticity, and muscle rigidity, which in rare cases has progressed to rhabdomyolysis (muscle breakdown), multiple organ-system failure, and death. While this warning is specific to the pump-delivered form, a similar (though usually less severe) withdrawal syndrome can occur with oral baclofen. Therefore, oral baclofen must also be tapered slowly under medical supervision.
Report any unusual symptoms to your healthcare provider immediately to ensure your treatment plan remains safe and effective.
To ensure safety while taking baclofen, healthcare providers may require periodic testing:
Baclofen frequently causes drowsiness, dizziness, and blurred vision. You should not drive a vehicle, operate heavy machinery, or engage in hazardous activities until you know how baclofen affects you. The impairment is often most severe during the first few weeks of treatment or after a dose increase.
Alcohol must be strictly avoided while taking baclofen. Alcohol is also a CNS depressant, and combining it with baclofen can lead to dangerous levels of sedation, respiratory depression, and loss of consciousness. The combination significantly increases the risk of fatal overdose.
If you and your doctor decide to stop baclofen, the dose must be reduced gradually over a period of at least 1 to 2 weeks. If you have been on high doses for a long time, the taper may take even longer. Abruptly stopping the medication is dangerous and can lead to a medical crisis.
> Important: Discuss all your medical conditions, including any history of kidney disease or seizures, with your healthcare provider before starting Baclofen.
Baclofen may interfere with certain laboratory results:
For each major interaction, the primary concern is usually pharmacodynamic synergism, where two drugs work in different ways to produce the same dangerous result (e.g., both slowing the heart or breath). Management strategies usually involve starting with very low doses and having a caregiver monitor the patient's breathing and alertness.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking to prevent dangerous interactions.
There is no documented cross-sensitivity between baclofen and other skeletal muscle relaxants like cyclobenzaprine or carisoprodol, as they belong to different chemical classes. However, patients who have had severe reactions to other GABA-ergic drugs (like gamma-hydroxybutyrate) should be monitored closely.
> Important: Your healthcare provider will evaluate your complete medical history, including kidney function and psychiatric history, before prescribing Baclofen.
Baclofen is used to treat spasticity in children, but safety and effectiveness in children under the age of 12 for the oral tablet form have not been formally established by the FDA, though it is widely used off-label. The intrathecal form is approved for children as young as 4 years old. In pediatric patients, the primary concern is the potential for the drug to interfere with cognitive development or cause excessive weakness that hinders physical therapy. Dosing must be very carefully titrated by a specialist.
Clinical studies of baclofen did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. However, clinical experience suggests that elderly patients have a higher incidence of adverse reactions, particularly confusion, hallucinations, and severe sedation. Because elderly patients are more likely to have decreased renal function, dose selection should be cautious, usually starting at the low end of the dosing range.
This is the most critical special population for baclofen. In patients with renal impairment, the half-life of baclofen is significantly prolonged. Even mild renal impairment can lead to drug accumulation.
No specific dose adjustments are provided in the manufacturer's labeling for patients with hepatic impairment, as the liver is not the primary route of elimination. However, these patients should still be monitored for general drug tolerance.
> Important: Special populations require individualized medical assessment and frequent monitoring to ensure safety.
The therapeutic effect of baclofen is primarily seen in the reduction of involuntary flexor and extensor spasms and resistance to passive movement. It has a relatively rapid onset of action (within hours), but the full clinical benefit for chronic spasticity may take several days or weeks of titration to realize. Baclofen does not have direct action on the neuromuscular junction or the muscle fibers themselves; its effect is entirely mediated through the CNS.
| Parameter | Value |
|---|---|
| Bioavailability | 70% - 85% |
| Protein Binding | ~30% |
| Half-life | 2.5 - 4 hours (Plasma) |
| Tmax | 2 - 3 hours |
| Metabolism | Minimal hepatic (~15%) |
| Excretion | Renal 70-80% (Unchanged), Fecal 10-20% |
Baclofen is classified as a Skeletal Muscle Relaxant, Central-Acting. Within this group, it is specifically a GABA-B Agonist. It is distinct from other relaxants like cyclobenzaprine (which acts more like a tricyclic antidepressant) or diazepam (which acts on GABA-A receptors).